DNDN - Dendreon Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DNDN - Dendreon Corp.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (698)	9/25/2010 3:11:48 PM
From: Arthur Radley	Read Replies (1) of 751

finance.yahoo.com IMO--This is going to erode any potential that DNDN has when you consider cost and steps that one has to undergo for treatment with Provenge. Their efforts to expand manfg. facility is probably going to turn out to be a white elephant. I've thought from day one...........cost of Provenge and elaborate dosing is going to hurt revenue potential.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next